Bobby Sheng News Today

Bora Pharmaceuticals Co., Ltd. yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics manufacturer based in Minnesota, U.S., from its previous owners, Sawai Group Holdings and Sumitomo Corporation of Americas.

Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion.

Transaction is set to fuel global expansion

Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth and Maple Grove, Minn.

Bringing Taiwan to the World and the World to Taiwan

Taiwan, 21st September 2023: Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has today announced its merged with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization. Resulting i...

Bringing Taiwan to the World and the World to Taiwan

CDMO’s Taoyuan City plant is set to provide customers with products ranging from emulsions to gels.

Bora Pharmaceuticals, an international contract development and manufacturing organization (CDMO), has announced the opening of a new state-of-the-art facility in Taoyuan City, Taiwan.

Bora establishes a leadership position in Taiwans CDMO sector as it continues to expand into the global CDMO market